Results 91 to 100 of about 2,828,690 (175)

Supplemental Table2 - Supplemental material for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders

, 2018
Supplemental material, Supplemental Table2 for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders by Susanna Asseyer, Felix Schmidt, Claudia Chien, Michael Scheel, Klemens Ruprecht, Judith Bellmann-Strobl, Alexander U ...
Judith Bellmann-Strobl (96062), Michael Scheel (445740), Alexander U Brandt (5705579), Felix Schmidt (312801), Friedemann Paul (25657), Susanna Asseyer (5705573), Claudia Chien (5705576), Klemens Ruprecht (187598)   +7 more
core   +1 more source

Reframing the Gut–Brain Axis: The Gut Wall as a Neural Immune Interface in Multiple Sclerosis and Autoimmune Neurological Diseases

Annals of Neurology, Volume 100, Issue 5, Page 915-930, November 2026.
Gut wall physiology in multiple sclerosis (MS) and autoimmune neurologic diseases remains underexplored but may span gut barrier dysfunction, enteric glial targeting, mucosal immune dysregulation, and autoimmune targets within the enteric nervous system (ENS).
Federico Montini, Sean J. Pittock, Laura Cacciaguerra, Howard L. Weiner, Luke A. Schwerdtfeger   +4 more
wiley   +1 more source

Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic Era

, 2020
Sherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, Nevin M Shalaby, Amr Hassan, Alaa Elmazny, Ehab Shaker, Mona AF Nada, Sandra M Ahmed, Mohamed I Hegazy, Husam S Mourad, Ahmed Abdelalim, Rehab Magdy, Alshimaa S Othman, Doaa A Mekkawy, Nirmeen A Kishk ...
Nada MAF, Elmazny A, Othman AS, Ahmed SM, Shehata HS, Hegazy MI, Mekkawy DA, Abdel-Naseer M, Abdelalim A, Shaker E, Shalaby NM, Kishk NA, Hassan A, Mourad HS, Hamdy SM, Magdy R   +15 more
core  

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He, Jingjing Zeng, Guoqing Wang, Yuxin Li, Feng Zhang   +4 more
wiley   +1 more source

Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences

, 2019
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are autoimmune demyelinating diseases of the central nervous system. Neuromyelitis optica was considered a variant of MS until the discovery of NMO-IgG in 2004, which changed our
Zhang, Lu, Li, Bin, Tian, Jing-Yuan
core  

Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neutrophils exhibit remarkable functional plasticity and play dual roles in tissue protection and disease progression. This review summarizes their key biological functions and highlights the shift from conventional broad‐spectrum interventions to neutrophil‐based drug delivery systems.
Yibing Zhang, Siwen Wu, Yusi Wang, Die Hu, Li Yang   +4 more
wiley   +1 more source

Supplemental Table1 - Supplemental material for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders

, 2018
Supplemental material, Supplemental Table1 for Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders by Susanna Asseyer, Felix Schmidt, Claudia Chien, Michael Scheel, Klemens Ruprecht, Judith Bellmann-Strobl, Alexander U ...
Judith Bellmann-Strobl (96062), Michael Scheel (445740), Alexander U Brandt (5705579), Felix Schmidt (312801), Friedemann Paul (25657), Susanna Asseyer (5705573), Claudia Chien (5705576), Klemens Ruprecht (187598)   +7 more
core   +1 more source

Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series

Reumatismo, 2017
Demyelinating syndrome (DS) is a rare manifestation of systemic lupus erythematosus (SLE) (1%) with high clinical heterogeneity and potentially severe prognosis. It can represent a diagnostic and therapeutic challenge for clinicians.
E. Chessa, M. Piga, A. Floris, A. Mathieu, A. Cauli   +4 more
doaj   +1 more source

Opsoclonus‐Myoclonus‐Ataxia Revealing Underlying Neuromyelitis Optica Spectrum Disorder

Movement Disorders Clinical Practice, EarlyView.
Ana Silvia Sobreira Lima Verde, Flávia de Paiva Santos Rolim, Amanda Vale Catunda, José Orlando Ferreira Tomé Filho, Milena Sales Pitombeira, Fernanda Martins Maia Carvalho, Paula Camila Alves de Assis Pereira Matos   +6 more
wiley   +1 more source

Absolute Counts of Circulating T Follicular Helper Cell Subsets in Acute‐Phase AQP4‐IgG–Positive Neuromyelitis Optica Spectrum Disorder

Clinical and Experimental Neuroimmunology, Volume 17, Issue 4, November 2026.
ABSTRACT Objectives Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease characterized by pathogenic anti‐aquaporin‐4 (AQP4) antibodies. Previous studies have shown increased circulating T follicular helper (cTfh) cells and altered Tfh subset frequencies in NMOSD, but the absolute counts of Tfh subsets remain unclear. We
Takafumi Hosokawa, Hideto Nakajima, Manami Matsushita, Takahiro Akamatsu, Shoji Ogawa, Shin Ota, Hiroko Tanada, Shigeki Arawaka   +7 more
wiley   +1 more source